Roman Sergeevich Knyazev
Director/Board Member bij PHARMSYNTHEZ
Profiel
Roman Sergeevich Knyazev is currently a Director at Pharmsynthez PJSC, Nanolek Holding Ltd., and Tsentr PETAR LLC.
He previously held positions as a Non-Executive Director at Xenetic Biosciences (UK) Ltd.
and Xenetic Biosciences, Inc., an Investment Director at Rusnano OJSC and Rusnano Management Co. LLC, and a Director at Lipoxen Technologies Ltd.
and SynBio LLC.
Knyazev received an undergraduate degree from Moscow State University Lomonosov.
Actieve functies van Roman Sergeevich Knyazev
Bedrijven | Functie | Begin |
---|---|---|
PHARMSYNTHEZ | Director/Board Member | 20-02-2013 |
Nanolek Holding Ltd.
Nanolek Holding Ltd. BiotechnologyHealth Technology Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services. | Director/Board Member | 01-01-2013 |
Tsentr PETAR LLC | Director/Board Member | 01-01-2012 |
Eerdere bekende functies van Roman Sergeevich Knyazev
Bedrijven | Functie | Einde |
---|---|---|
XENETIC BIOSCIENCES, INC. | Director/Board Member | 25-09-2019 |
Rusnano OJSC
Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Chief Investment Officer | 01-01-2014 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Director/Board Member | 01-01-2013 |
Rusnano Management Co. LLC
Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Chief Investment Officer | - |
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the private company is based in London, UK. | Director/Board Member | - |
Opleiding van Roman Sergeevich Knyazev
Moscow State University Lomonosov | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PHARMSYNTHEZ | Health Technology |
XENETIC BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the private company is based in London, UK. | Health Technology |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Rusnano OJSC
Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Commercial Services |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
Nanolek Holding Ltd.
Nanolek Holding Ltd. BiotechnologyHealth Technology Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services. | Health Technology |
Rusnano Management Co. LLC
Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Finance |
Tsentr PETAR LLC |